ABIOMED CEO Michael Minogue's 2018 pay slips 16% to $10M
ABIOMED reports 2018 executive compensation
By ExecPay News
Published: June 22, 2018
ABIOMED reported fiscal year 2018 executive compensation information on June 22, 2018.
In 2018, six ABIOMED executives received on average a compensation package of $3.1M, a 29% decrease compared to previous year.
Average pay of disclosed executives at ABIOMED
Michael R. Minogue, Chief Executive Officer, received $10M in total, which decreased by 16% compared to 2017. 56% of Minogue's compensation, or $5.7M, was in stock awards. Minogue also received $2.2M in non-equity incentive plan, $1.6M in option awards, as well as $718K in salary.
David M. Weber, Chief Operating Officer, received a compensation package of $2.2M, which decreased by 20% compared to previous year. 43% of the compensation package, or $942K, was in stock awards.
Michael G. Howley, Vice President and General Manager, Global Sales, earned $1.9M in 2018, a 15% decrease compared to previous year.
William J. Bolt, Senior Vice President, Global Quality, Regulatory and Clinical Operations, received $1.6M in 2018, which decreases by 24% compared to 2017.
Michael J. Tomsicek, Chief Financial Officer, earned $1.3M in 2018, a 41% decrease compared to previous year.
Ian McLeod, Chief Financial Officer, received $952K in 2018.
ABIOMED's fiscal year ends on March 31.
Related executives
Michael Minogue
ABIOMED
Chief Executive Officer
Michael Tomsicek
ABIOMED
Chief Financial Officer
Ian McLeod
ABIOMED
Chief Financial Officer
David Weber
ABIOMED
Chief Operating Officer
William Bolt
ABIOMED
Senior Vice President, Global Quality, Regulatory and Clinical Operations
Michael Howley
ABIOMED
Vice President and General Manager, Global Sales
You may also like
Source: SEC filing on June 22, 2018.